Aescin treatment of acute cerebral infarction Observation of 41 Cases.docVIP

 PAGE \* MERGEFORMAT 11 Aescin treatment of acute cerebral infarction Observation of 41 Cases [Abstract] Objective To observe aescin the treatment of acute cerebral infarction. Methods January 2003 ~ January 2006 were treated 82 patients with acute cerebral infarction were randomly divided into treatment group and control group of 41 cases. The control group the conventional treatment group in the conventional treatment based on the use aescin, comparing treatment effects, and neurological deficit scores (NDS. results aescin treatment can significantly reduce the increased intracranial pressure and cerebral edema, with the control group there was significant difference (P lt;0.05, treatment group, significant effect was significantly better than the control group (P lt;0.05, treatment group after treatment, 15 d, 25 dNDS with the control group decreased significantly (P lt;0.01 . Conclusion aescinate by promoting the secretion of adrenal cortisol play a hormone-like anti-inflammatory effect of anti-exudative swelling, can avoid adverse reactions caused by a large number of hormone for the treatment of acute cerebral infarction is safe and effective. [Keywords:] mannitol in acute cerebral infarction aescin Often accompanied by cerebral edema in acute cerebral infarction and effective control of cerebral edema, has a direct impact on prognosis, therefore, the treatment of cerebral edema is particularly important. Our hospital in January 2003 ~ January 2006 on the basis of routine treatment, plus aescinate (no Xi Kaifu pharmaceutical production, 10mg / support the treatment of acute cerebral infarction caused by cerebral edema in 41 cases, achieved good treatment effect, are reported below. Materials and Methods 1. General information on all the cases were hospital patients, cerebral infarction occurred in a few hours to 3 days, have varying degrees of symptoms of nervous system position, CT or MRI confirmed that different parts of infarct sizes, an